CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice.

Transplantation
Zhidan XiangDeng-Ping Yin

Abstract

We characterized the role of T cell subsets and major histocompatibility complex molecules in allograft rejection and recurrence of autoimmune diabetes. Adoptive cell transfer and vascularized segmental pancreas transplantation were performed in mice. In an alloimmune response model, transfer of nondiabetic CD4, but not CD8 T cells, elicited pancreas allograft rejection in streptozotocin (STZ)-induced diabetic NOD/scid mice. Pancreas allografts were acutely rejected in STZ-induced diabetic NOD/beta2m mice (confirmed the absence of major histocompatibility complex [MHC] class I and CD8 T cells) and permanently accepted in NOD/CIIT mice (confirmed the absence of MHC class II and CD4 T cells). The results suggest that rejection of pancreas allograft is CD4-dependent and MHC class I-independent. In the autoimmune diabetes model, whole spleen cells obtained from diabetic NOD mice induced autoimmune diabetes in NOD/scid and NOD/CIIT mice, but the onset of diabetes was delayed in NOD/beta2m mice. However, the purified diabetic T cells failed to elicit autoimmune diabetes in NOD/beta2m mice. NOD/scid and NOD/CIIT pancreas grafts were acutely destroyed whereas four of six NOD/beta2m pancreas grafts were permanently accepted in autoimmun...Continue Reading

References

Feb 1, 1991·The Journal of Experimental Medicine·S E AltersC G Fathman
Jan 1, 1995·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·H Klinkmann, J Vienken
Nov 1, 1996·The Journal of Experimental Medicine·N R KriegerC G Fathman
Nov 27, 2002·Transplantation·Deng-Ping YinAnita S Chong
Mar 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Petra KleindienstThomas Brocker
Jan 26, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D YinA S Chong
Mar 22, 2006·Transplantation Proceedings·R Kandaswamy, D E R Sutherland
Jun 23, 2006·Methods in Molecular Biology·Jonathan R T LakeyA M James Shapiro

❮ Previous
Next ❯

Citations

Aug 7, 2009·European Journal of Immunology·Shuguang PangBo Wang
Nov 3, 2010·Journal of Zhejiang University. Science. B·Xiao-jun XieShu-sen Zheng
Jan 12, 2010·The Journal of Clinical Endocrinology and Metabolism·Philippe A HalbanGordon C Weir
Jul 1, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.